Randomized split-face study using a post-procedural biotech cellulose mask to improve patient comfort and downtime

Area of Science:

• Dermatology
• Biotechnology
• Medical Aesthetics

Background:

• Limited prospective randomized studies exist for post-procedural treatments.
• Many treatments claim to improve comfort and reduce downtime, but lack robust scientific validation.

Purpose of the Study:

• To evaluate the safety and efficacy of a novel biotech cellulose mask as a post-procedural application.
• To assess the mask's impact on patient comfort, facial temperature, erythema, and swelling.

Main Methods:

• A randomized controlled trial involving 15 patients undergoing microneedling with radiofrequency, non-ablative fractional laser, or full erbium:YAG resurfacing.
• The biotech cellulose mask was applied to one side of the face post-procedure and daily until healing, with the other side serving as a control.
• Objective measurements included standardized photos and thermal imaging, supplemented by subjective patient questionnaires and blind evaluator assessments.

Main Results:

• Biotech cellulose mask application led to a significant average reduction of 2.2°C in facial temperature compared to the control side across all treatment groups.
• Patients reported immediate and sustained relief from pain and heat, with 13/15 experiencing less discomfort 30 minutes post-application.
• Reduced erythema and swelling were observed, with blind evaluators correctly identifying the masked side 80% of the time, and patients reporting significantly less swelling on Days 1 and 2.

Conclusions:

• The biotech cellulose mask effectively decreased facial temperature, pain, and heat sensation post-procedure.
• The mask demonstrated a significant role in reducing patient downtime and improving overall comfort.
• No adverse side effects were reported by subjects utilizing the biotech cellulose mask during the study period.